Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
EGFR | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 9.88E3 | Evidence | |||||
EGFR | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 8.52E3 | Evidence | |||||
EGFR | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 4.98E3 | Evidence | |||||
EGFR | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 200.0 | Evidence | |||||
EGFR | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 200.0 | Evidence | |||||
EGFR | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 200.0 | Evidence | |||||
EGFR | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 200.0 | Evidence | |||||
EGFR | NCK2 | NCK2: Cytoplasmic protein NCK2 | 200.0 | Evidence | |||||
EGFR | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 200.0 | Evidence | |||||
EGFR | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 125.0 | Evidence | |||||
EGFR | CRKL | CRKL: Crk-like protein | 121.0 | Evidence | |||||
EGFR | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 121.0 | Evidence | |||||
EGFR | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 121.0 | Evidence | |||||
EGFR | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 121.0 | Evidence | |||||
EGFR | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 117.0 | Evidence | |||||
EGFR | PTK6 | PTK6, BRK: Tyrosine-protein kinase 6 | 117.0 | Evidence | |||||
EGFR | STAT3 | 117.0 | Evidence | ||||||
EGFR | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 110.0 | Evidence | |||||
EGFR | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 110.0 | Evidence | |||||
EGFR | LYN | LYN: Tyrosine-protein kinase Lyn | 89.20 | Evidence | |||||
EGFR | BMX | N/A | 89.20 | Evidence | |||||
EGFR | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 89.20 | Evidence | |||||
EGFR | INSL3 | JAK3: Tyrosine-protein kinase JAK3 | 89.20 | Evidence | |||||
EGFR | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 89.20 | Evidence | |||||
EGFR | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 89.20 | Evidence | |||||
EGFR | SYK | SYK: Tyrosine-protein kinase SYK | 79.90 | Evidence | |||||
EGFR | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 79.90 | Evidence | |||||
EGFR | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 79.90 | Evidence | |||||
EGFR | HCK | N/A | 79.90 | Evidence | |||||
EGFR | JAK1 | 79.90 | Evidence | ||||||
EGFR | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 67.1 | Evidence | |||||
EGFR | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 64.40 | Evidence | |||||
EGFR | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 44.00 | Evidence | |||||
EGFR | PTK2 | PTK2, FAK, FAK1: Focal adhesion kinase 1 | 40.60 | Evidence | |||||
EGFR | INSR | INSR: Insulin receptor precursor | 33.90 | Evidence | |||||
EGFR | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | KIT | KIT: Mast/stem cell growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 33.90 | Evidence | |||||
EGFR | GRB7 | GRB7: Growth factor receptor-bound protein 7 | 30.10 | Evidence | |||||
EGFR | GRAP | GRAP: GRB2-related adapter protein | 23.20 | Evidence | |||||
EGFR | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 20.50 | Evidence | |||||
EGFR | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 20.50 | Evidence | |||||
EGFR | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 20.50 | Evidence | |||||
EGFR | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 19.70 | Evidence | |||||
EGFR | HLA-A | HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor | 19.70 | Evidence | |||||
EGFR | IL6ST | IL6ST: Interleukin-6 receptor subunit beta precursor | 19.70 | Evidence | |||||
EGFR | ITGB4 | N/A | 19.70 | Evidence | |||||
EGFR | EGF | EGF: Pro-epidermal growth factor precursor | 19.70 | Evidence | |||||
EGFR | ICAM3 | ICAM3: Intercellular adhesion molecule 3 precursor | 19.70 | Evidence | |||||
EGFR | TGFA | TGFA: Protransforming growth factor alpha precursor [Contains: Transforming grow | 19.70 | Evidence | |||||
EGFR | BTC | BTC: Probetacellulin precursor [Contains: Betacellulin | 19.70 | Evidence | |||||
EGFR | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 17.60 | Evidence | |||||
EGFR | ERBB4 | ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor | 17.60 | Evidence | |||||
EGFR | JAG2 | JAG2: Jagged-2 precursor | 17.60 | Evidence | |||||
EGFR | GHR | GHR: Growth hormone receptor precursor | 15.00 | Evidence | |||||
EGFR | EPOR | EPOR: Erythropoietin receptor precursor | 15.00 | Evidence | |||||
EGFR | STAM2 | STAM2: Signal transducing adapter molecule 2 | 13.50 | Evidence | |||||
EGFR | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 13.50 | Evidence | |||||
EGFR | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 13.50 | Evidence | |||||
EGFR | MT2A | MT2A, CES1, MT2: Metallothionein-2 | 13.00 | Evidence | |||||
EGFR | NF2 | NF2, SCH: Merlin | 13.00 | Evidence | |||||
EGFR | IGFBP7 | IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor | 13.00 | Evidence | |||||
EGFR | VASP | VASP: Vasodilator-stimulated phosphoprotein | 13.00 | Evidence | |||||
EGFR | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 11.60 | Evidence | |||||
EGFR | DOK1 | DOK1: Docking protein 1 | 11.60 | Evidence | |||||
EGFR | CAPN2 | CAPN2, CANPL2: Calpain-2 catalytic subunit precursor | 11.60 | Evidence | |||||
EGFR | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 11.60 | Evidence | |||||
EGFR | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 11.60 | Evidence | |||||
EGFR | BCAN | BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor | 11.60 | Evidence | |||||
EGFR | COL5A1 | N/A | 11.40 | Evidence | |||||
EGFR | SHC2 | N/A | 10.70 | Evidence | |||||
EGFR | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 10.30 | Evidence | |||||
EGFR | ATP2A3 | ATP2A3: Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 9.96 | Evidence | |||||
EGFR | EFNA1 | EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor | 9.06 | Evidence | |||||
EGFR | CD82 | CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen | 8.92 | Evidence | |||||
EGFR | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 8.92 | Evidence | |||||
EGFR | GNAT1 | GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit | 8.92 | Evidence | |||||
EGFR | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 8.89 | Evidence | |||||
EGFR | STAM | STAM, STAM1: Signal transducing adapter molecule 1 | 8.89 | Evidence | |||||
EGFR | SOS1 | SOS1: Son of sevenless homolog 1 | 8.55 | Evidence | |||||
EGFR | MET | MET: Hepatocyte growth factor receptor precursor | 7.59 | Evidence | |||||
EGFR | ANXA2 | ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 | 6.24 | Evidence | |||||
EGFR | YLPM1 | N/A | 6.14 | Evidence | |||||
EGFR | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 5.87 | Evidence | |||||
EGFR | CSH2 | GH1: Somatotropin precursor | 5.87 | Evidence | |||||
EGFR | GRIA3 | GRIA3, GLUR3, GLURC: Glutamate receptor 3 precursor | 5.59 | Evidence | |||||
EGFR | GRIN1 | GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor | 5.59 | Evidence | |||||
EGFR | CAV1 | CAV1, CAV: Caveolin-1 | 5.50 | Evidence | |||||
EGFR | THOP1 | THOP1: Thimet oligopeptidase | 5.26 | Evidence | |||||
EGFR | HSP90B1 | HSP90B1, TRA1: Endoplasmin precursor | 5.26 | Evidence | |||||
EGFR | HSP90AA1 | Hsp89-alpha-delta-N | 5.26 | Evidence | |||||
EGFR | KLK6 | KLK6, PRSS18, PRSS9: Kallikrein-6 precursor | 5.26 | Evidence | |||||
EGFR | JUP | JUP, CTNNG, DP3: Junction plakoglobin | 5.26 | Evidence | |||||
EGFR | WASPIP | N/A | 5.26 | Evidence | |||||
EGFR | ALK | ALK: ALK tyrosine kinase receptor precursor | 5.26 | Evidence | |||||
EGFR | DPP8 | DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 | 5.26 | Evidence | |||||
EGFR | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 4.78 | Evidence | |||||
EGFR | SERPINA6 | SERPINA6, CBG: Corticosteroid-binding globulin precursor | 4.78 | Evidence | |||||
EGFR | SERPINA3 | N/A | 4.78 | Evidence | |||||
EGFR | ILK | ILK, ILK1, ILK2: Integrin-linked protein kinase | 4.28 | Evidence | |||||
EGFR | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 4.03 | Evidence | |||||
EGFR | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 4.01 | Evidence | |||||
EGFR | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 4.01 | Evidence | |||||
EGFR | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 4.01 | Evidence | |||||
EGFR | HGS | HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate | 3.61 | Evidence | |||||
EGFR | ASGR2 | ASGR2: Asialoglycoprotein receptor 2 | 3.34 | Evidence | |||||
EGFR | TRPV2 | TRPV2: Uncharacterized protein TRPV2 | 3.18 | Evidence | |||||
EGFR | SIGLEC6 | N/A | 3.18 | Evidence | |||||
EGFR | IL31RA | IL31RA, CRL3, UNQ6368/PRO21073/PRO21384, GPL: Interleukin-31 receptor A precurso | 3.18 | Evidence | |||||
EGFR | TSPAN9 | TSPAN9, NET5: Tetraspanin-9 | 3.05 | Evidence | |||||
EGFR | CD37 | CD37, TSPAN26: Leukocyte antigen CD37 | 3.05 | Evidence | |||||
EGFR | STK39 | STK39, SPAK: STE20/SPS1-related proline-alanine-rich protein kinase | 2.99 | Evidence | |||||
EGFR | DLG1 | N/A | 2.99 | Evidence | |||||
EGFR | CELSR1 | CELSR1, CDHF9, FMI2: Cadherin EGF LAG seven-pass G-type receptor 1 precursor | 2.85 | Evidence | |||||
EGFR | EFNA2 | EFNA2, EPLG6, LERK6: Ephrin-A2 precursor | 2.60 | Evidence | |||||
EGFR | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 2.28 | Evidence | |||||
EGFR | RAB40B | RAB40B, SEC4L: Ras-related protein Rab-40B | 2.24 | Evidence | |||||
EGFR | HYAL2 | HYAL2, LUCA2: Hyaluronidase-2 precursor | 2.24 | Evidence | |||||
EGFR | EFNA3 | EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor | 1.91 | Evidence | |||||
EGFR | EFNA5 | EFNA5, EPLG7, LERK7: Ephrin-A5 precursor | 1.91 | Evidence | |||||
EGFR | ITPKA | ITPKA: Inositol-trisphosphate 3-kinase A | 1.79 | Evidence | |||||
EGFR | ACTG1 | ACTB: Actin, cytoplasmic 1 | 1.78 | Evidence | |||||
EGFR | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 1.67 | Evidence | |||||
EGFR | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 1.53 | Evidence | |||||
EGFR | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.53 | Evidence | |||||
EGFR | CAMKK1 | N/A | 1.53 | Evidence | |||||
EGFR | SERPINF2 | SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor | 1.32 | Evidence | |||||
EGFR | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 1.16 | Evidence |